Achieve Life Sciences (ACHV) Reports In-Line Q2 EPS

Achieve Life Sciences (NASDAQ: ACHV) reported Q2 EPS of ($0.37), in-line with the analyst estimate of ($0.37).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Freedom Broker Downgrades Karooooo Ltd. (KARO) to Hold
• Apple and DoJ discussing antitrust settlement - report